How big is the extended release drug market?

Now the pattern has been changed to modified release dosage forms to achieve better therapeutic target.Extended release drugsis a type of dosage forms which allows a twofold reduction in frequency of dosage administered in the body.Market Analysis and Insights Global Extended Release Drug MarketThe global Extended Release Drug market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic .

BUY CHAPTERS

Extended Release Drug Market Insights and Forecast to 2028

Q: Who are the key players in the extended release drug market?

Some of the key players are Pfizer Inc, Mallinckrodt plc, TEVA, Johnson & Johnson, Endo Pharmaceuticals, Purdue Pharma, Mylan NV, Hisamitsu Pharmaceutical, Sun Pharmaceutical Industries, Others.

Code: QYRE-Auto-23G2678

Report

February 2022

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Mallinckrodt plc

TEVA

Johnson & Johnson

Endo Pharmaceuticals

Purdue Pharma

Mylan NV

Hisamitsu Pharmaceutical

Sun Pharmaceutical Industries

Extended Release Drug Market Outlook - 2028

The global Extended Release Drug market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Sustained Release Drug accounting for % of the Extended Release Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.

China Extended Release Drug market size is valued at US$ million in 2021, while the North America and Europe Extended Release Drug are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Extended Release Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Extended Release Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Extended Release Drug market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Extended Release Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Extended Release Drug market.

Extended Release Drug Market Scope and Market Size

Extended Release Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Extended Release Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Sustained Release Drug
Controlled Release Drug

Segment by Application

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Company

Pfizer
Mallinckrodt
Teva
Johnson & Johnson
Endo Pharmaceuticals
Purdue Pharma
Mylan
Hisamitsu Pharmaceutical
Sun Pharmaceutical Industries

By Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Extended Release Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Sustained Release Drug

1.2.3 Controlled Release Drug

1.3 Market by Application

1.3.1 Global Extended Release Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Extended Release Drug Market Perspective (2017-2028)

2.2 Extended Release Drug Growth Trends by Region

2.2.1 Extended Release Drug Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Extended Release Drug Historic Market Size by Region (2017-2022)

2.2.3 Extended Release Drug Forecasted Market Size by Region (2023-2028)

2.3 Extended Release Drug Market Dynamics

2.3.1 Extended Release Drug Industry Trends

2.3.2 Extended Release Drug Market Drivers

2.3.3 Extended Release Drug Market Challenges

2.3.4 Extended Release Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Extended Release Drug Players by Revenue

3.1.1 Global Top Extended Release Drug Players by Revenue (2017-2022)

3.1.2 Global Extended Release Drug Revenue Market Share by Players (2017-2022)

3.2 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Extended Release Drug Revenue

3.4 Global Extended Release Drug Market Concentration Ratio

3.4.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2021

3.5 Extended Release Drug Key Players Head office and Area Served

3.6 Key Players Extended Release Drug Product Solution and Service

3.7 Date of Enter into Extended Release Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Extended Release Drug Breakdown Data by Type

4.1 Global Extended Release Drug Historic Market Size by Type (2017-2022)

4.2 Global Extended Release Drug Forecasted Market Size by Type (2023-2028)

5 Extended Release Drug Breakdown Data by Application

5.1 Global Extended Release Drug Historic Market Size by Application (2017-2022)

5.2 Global Extended Release Drug Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Extended Release Drug Market Size (2017-2028)

6.2 North America Extended Release Drug Market Size by Type

6.2.1 North America Extended Release Drug Market Size by Type (2017-2022)

6.2.2 North America Extended Release Drug Market Size by Type (2023-2028)

6.2.3 North America Extended Release Drug Market Share by Type (2017-2028)

6.3 North America Extended Release Drug Market Size by Application

6.3.1 North America Extended Release Drug Market Size by Application (2017-2022)

6.3.2 North America Extended Release Drug Market Size by Application (2023-2028)

6.3.3 North America Extended Release Drug Market Share by Application (2017-2028)

6.4 North America Extended Release Drug Market Size by Country

6.4.1 North America Extended Release Drug Market Size by Country (2017-2022)

6.4.2 North America Extended Release Drug Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Extended Release Drug Market Size (2017-2028)

7.2 Europe Extended Release Drug Market Size by Type

7.2.1 Europe Extended Release Drug Market Size by Type (2017-2022)

7.2.2 Europe Extended Release Drug Market Size by Type (2023-2028)

7.2.3 Europe Extended Release Drug Market Share by Type (2017-2028)

7.3 Europe Extended Release Drug Market Size by Application

7.3.1 Europe Extended Release Drug Market Size by Application (2017-2022)

7.3.2 Europe Extended Release Drug Market Size by Application (2023-2028)

7.3.3 Europe Extended Release Drug Market Share by Application (2017-2028)

7.4 Europe Extended Release Drug Market Size by Country

7.4.1 Europe Extended Release Drug Market Size by Country (2017-2022)

7.4.2 Europe Extended Release Drug Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Extended Release Drug Market Size (2017-2028)

8.2 Asia-Pacific Extended Release Drug Market Size by Type

8.2.1 Asia-Pacific Extended Release Drug Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Extended Release Drug Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Extended Release Drug Market Share by Type (2017-2028)

8.3 Asia-Pacific Extended Release Drug Market Size by Application

8.3.1 Asia-Pacific Extended Release Drug Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Extended Release Drug Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Extended Release Drug Market Share by Application (2017-2028)

8.4 Asia-Pacific Extended Release Drug Market Size by Region

8.4.1 Asia-Pacific Extended Release Drug Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Extended Release Drug Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Extended Release Drug Market Size (2017-2028)

9.2 Latin America Extended Release Drug Market Size by Type

9.2.1 Latin America Extended Release Drug Market Size by Type (2017-2022)

9.2.2 Latin America Extended Release Drug Market Size by Type (2023-2028)

9.2.3 Latin America Extended Release Drug Market Share by Type (2017-2028)

9.3 Latin America Extended Release Drug Market Size by Application

9.3.1 Latin America Extended Release Drug Market Size by Application (2017-2022)

9.3.2 Latin America Extended Release Drug Market Size by Application (2023-2028)

9.3.3 Latin America Extended Release Drug Market Share by Application (2017-2028)

9.4 Latin America Extended Release Drug Market Size by Country

9.4.1 Latin America Extended Release Drug Market Size by Country (2017-2022)

9.4.2 Latin America Extended Release Drug Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Extended Release Drug Market Size (2017-2028)

10.2 Middle East & Africa Extended Release Drug Market Size by Type

10.2.1 Middle East & Africa Extended Release Drug Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Extended Release Drug Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Extended Release Drug Market Share by Type (2017-2028)

10.3 Middle East & Africa Extended Release Drug Market Size by Application

10.3.1 Middle East & Africa Extended Release Drug Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Extended Release Drug Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Extended Release Drug Market Share by Application (2017-2028)

10.4 Middle East & Africa Extended Release Drug Market Size by Country

10.4.1 Middle East & Africa Extended Release Drug Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Extended Release Drug Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Extended Release Drug Introduction

11.1.4 Pfizer Revenue in Extended Release Drug Business (2017-2022)

11.1.5 Pfizer Recent Developments

11.2 Mallinckrodt

11.2.1 Mallinckrodt Company Details

11.2.2 Mallinckrodt Business Overview

11.2.3 Mallinckrodt Extended Release Drug Introduction

11.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2017-2022)

11.2.5 Mallinckrodt Recent Developments

11.3 Teva

11.3.1 Teva Company Details

11.3.2 Teva Business Overview

11.3.3 Teva Extended Release Drug Introduction

11.3.4 Teva Revenue in Extended Release Drug Business (2017-2022)

11.3.5 Teva Recent Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Extended Release Drug Introduction

11.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2017-2022)

11.4.5 Johnson & Johnson Recent Developments

11.5 Endo Pharmaceuticals

11.5.1 Endo Pharmaceuticals Company Details

11.5.2 Endo Pharmaceuticals Business Overview

11.5.3 Endo Pharmaceuticals Extended Release Drug Introduction

11.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2017-2022)

11.5.5 Endo Pharmaceuticals Recent Developments

11.6 Purdue Pharma

11.6.1 Purdue Pharma Company Details

11.6.2 Purdue Pharma Business Overview

11.6.3 Purdue Pharma Extended Release Drug Introduction

11.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2017-2022)

11.6.5 Purdue Pharma Recent Developments

11.7 Mylan

11.7.1 Mylan Company Details

11.7.2 Mylan Business Overview

11.7.3 Mylan Extended Release Drug Introduction

11.7.4 Mylan Revenue in Extended Release Drug Business (2017-2022)

11.7.5 Mylan Recent Developments

11.8 Hisamitsu Pharmaceutical

11.8.1 Hisamitsu Pharmaceutical Company Details

11.8.2 Hisamitsu Pharmaceutical Business Overview

11.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction

11.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2017-2022)

11.8.5 Hisamitsu Pharmaceutical Recent Developments

11.9 Sun Pharmaceutical Industries

11.9.1 Sun Pharmaceutical Industries Company Details

11.9.2 Sun Pharmaceutical Industries Business Overview

11.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction

11.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2017-2022)

11.9.5 Sun Pharmaceutical Industries Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Mallinckrodt plc

TEVA

Johnson & Johnson

Endo Pharmaceuticals

Purdue Pharma

Mylan NV

Hisamitsu Pharmaceutical

Sun Pharmaceutical Industries

List of Tables

Table 1. Global Extended Release Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Sustained Release Drug

Table 3. Key Players of Controlled Release Drug

Table 4. Global Extended Release Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 5. Global Extended Release Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Extended Release Drug Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global Extended Release Drug Market Share by Region (2017-2022)

Table 8. Global Extended Release Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global Extended Release Drug Market Share by Region (2023-2028)

Table 10. Extended Release Drug Market Trends

Table 11. Extended Release Drug Market Drivers

Table 12. Extended Release Drug Market Challenges

Table 13. Extended Release Drug Market Restraints

Table 14. Global Extended Release Drug Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global Extended Release Drug Revenue Share by Players (2017-2022)

Table 16. Global Top Extended Release Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extended Release Drug as of 2021)

Table 17. Ranking of Global Top Extended Release Drug Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by Extended Release Drug Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Extended Release Drug Product Solution and Service

Table 21. Date of Enter into Extended Release Drug Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global Extended Release Drug Revenue Market Share by Type (2017-2022)

Table 25. Global Extended Release Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global Extended Release Drug Revenue Market Share by Type (2023-2028)

Table 27. Global Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global Extended Release Drug Revenue Share by Application (2017-2022)

Table 29. Global Extended Release Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global Extended Release Drug Revenue Share by Application (2023-2028)

Table 31. North America Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)

Table 32. North America Extended Release Drug Market Size by Type (2023-2028) & (US$ Million)

Table 33. North America Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)

Table 34. North America Extended Release Drug Market Size by Application (2023-2028) & (US$ Million)

Table 35. North America Extended Release Drug Market Size by Country (2017-2022) & (US$ Million)

Table 36. North America Extended Release Drug Market Size by Country (2023-2028) & (US$ Million)

Table 37. Europe Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)

Table 38. Europe Extended Release Drug Market Size by Type (2023-2028) & (US$ Million)

Table 39. Europe Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)

Table 40. Europe Extended Release Drug Market Size by Application (2023-2028) & (US$ Million)

Table 41. Europe Extended Release Drug Market Size by Country (2017-2022) & (US$ Million)

Table 42. Europe Extended Release Drug Market Size by Country (2023-2028) & (US$ Million)

Table 43. Asia Pacific Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)

Table 44. Asia Pacific Extended Release Drug Market Size by Type (2023-2028) & (US$ Million)

Table 45. Asia Pacific Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)

Table 46. Asia Pacific Extended Release Drug Market Size by Application (2023-2028) & (US$ Million)

Table 47. Asia Pacific Extended Release Drug Market Size by Region (2017-2022) & (US$ Million)

Table 48. Asia Pacific Extended Release Drug Market Size by Region (2023-2028) & (US$ Million)

Table 49. Latin America Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)

Table 50. Latin America Extended Release Drug Market Size by Type (2023-2028) & (US$ Million)

Table 51. Latin America Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)

Table 52. Latin America Extended Release Drug Market Size by Application (2023-2028) & (US$ Million)

Table 53. Latin America Extended Release Drug Market Size by Country (2017-2022) & (US$ Million)

Table 54. Latin America Extended Release Drug Market Size by Country (2023-2028) & (US$ Million)

Table 55. Middle East and Africa Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)

Table 56. Middle East and Africa Extended Release Drug Market Size by Type (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Extended Release Drug Market Size by Application (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Extended Release Drug Market Size by Country (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Extended Release Drug Market Size by Country (2023-2028) & (US$ Million)

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer Extended Release Drug Product

Table 64. Pfizer Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)

Table 65. Pfizer Recent Developments

Table 66. Mallinckrodt Company Details

Table 67. Mallinckrodt Business Overview

Table 68. Mallinckrodt Extended Release Drug Product

Table 69. Mallinckrodt Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)

Table 70. Mallinckrodt Recent Developments

Table 71. Teva Company Details

Table 72. Teva Business Overview

Table 73. Teva Extended Release Drug Product

Table 74. Teva Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)

Table 75. Teva Recent Developments

Table 76. Johnson & Johnson Company Details

Table 77. Johnson & Johnson Business Overview

Table 78. Johnson & Johnson Extended Release Drug Product

Table 79. Johnson & Johnson Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)

Table 80. Johnson & Johnson Recent Developments

Table 81. Endo Pharmaceuticals Company Details

Table 82. Endo Pharmaceuticals Business Overview

Table 83. Endo Pharmaceuticals Extended Release Drug Product

Table 84. Endo Pharmaceuticals Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)

Table 85. Endo Pharmaceuticals Recent Developments

Table 86. Purdue Pharma Company Details

Table 87. Purdue Pharma Business Overview

Table 88. Purdue Pharma Extended Release Drug Product

Table 89. Purdue Pharma Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)

Table 90. Purdue Pharma Recent Developments

Table 91. Mylan Company Details

Table 92. Mylan Business Overview

Table 93. Mylan Extended Release Drug Product

Table 94. Mylan Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)

Table 95. Mylan Recent Developments

Table 96. Hisamitsu Pharmaceutical Company Details

Table 97. Hisamitsu Pharmaceutical Business Overview

Table 98. Hisamitsu Pharmaceutical Extended Release Drug Product

Table 99. Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)

Table 100. Hisamitsu Pharmaceutical Recent Developments

Table 101. Sun Pharmaceutical Industries Company Details

Table 102. Sun Pharmaceutical Industries Business Overview

Table 103. Sun Pharmaceutical Industries Extended Release Drug Product

Table 104. Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)

Table 105. Sun Pharmaceutical Industries Recent Developments

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Extended Release Drug Market Share by Type: 2021 VS 2028

Figure 2. Sustained Release Drug Features

Figure 3. Controlled Release Drug Features

Figure 4. Global Extended Release Drug Market Share by Application: 2021 VS 2028

Figure 5. Hospital Pharmacy Case Studies

Figure 6. Retail Pharmacy Case Studies

Figure 7. Online Pharmacy Case Studies

Figure 8. Extended Release Drug Report Years Considered

Figure 9. Global Extended Release Drug Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 10. Global Extended Release Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Extended Release Drug Market Share by Region: 2021 VS 2028

Figure 12. Global Extended Release Drug Market Share by Players in 2021

Figure 13. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extended Release Drug as of 2021)

Figure 14. The Top 10 and 5 Players Market Share by Extended Release Drug Revenue in 2021

Figure 15. North America Extended Release Drug Market Size YoY (2017-2028) & (US$ Million)

Figure 16. North America Extended Release Drug Market Size Market Share by Type (2017-2028)

Figure 17. North America Extended Release Drug Market Size Market Share by Application (2017-2028)

Figure 18. North America Extended Release Drug Market Size Share by Country (2017-2028)

Figure 19. United States Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 20. Canada Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Europe Extended Release Drug Market Size YoY (2017-2028) & (US$ Million)

Figure 22. Europe Extended Release Drug Market Size Market Share by Type (2017-2028)

Figure 23. Europe Extended Release Drug Market Size Market Share by Application (2017-2028)

Figure 24. Europe Extended Release Drug Market Size Share by Country (2017-2028)

Figure 25. Germany Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. France Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. U.K. Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Italy Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Russia Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Nordic Countries Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Asia-Pacific Extended Release Drug Market Size YoY (2017-2028) & (US$ Million)

Figure 32. Asia Pacific Extended Release Drug Market Size Market Share by Type (2017-2028)

Figure 33. Asia Pacific Extended Release Drug Market Size Market Share by Application (2017-2028)

Figure 34. Asia Pacific Extended Release Drug Market Size Share by Region (2017-2028)

Figure 35. China Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Japan Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. South Korea Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Southeast Asia Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. India Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Australia Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 41. Latin America Extended Release Drug Market Size YoY (2017-2028) & (US$ Million)

Figure 42. Latin America Extended Release Drug Market Size Market Share by Type (2017-2028)

Figure 43. Latin America Extended Release Drug Market Size Market Share by Application (2017-2028)

Figure 44. Latin America Extended Release Drug Market Size Share by Country (2017-2028)

Figure 45. Mexico Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 46. Brazil Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Middle East & Africa Extended Release Drug Market Size YoY (2017-2028) & (US$ Million)

Figure 48. Middle East and Africa Extended Release Drug Market Size Market Share by Type (2017-2028)

Figure 49. Middle East and Africa Extended Release Drug Market Size Market Share by Application (2017-2028)

Figure 50. Middle East and Africa Extended Release Drug Market Size Share by Country (2017-2028)

Figure 51. Turkey Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 52. Saudi Arabia Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. UAE Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Pfizer Revenue Growth Rate in Extended Release Drug Business (2017-2022)

Figure 55. Mallinckrodt Revenue Growth Rate in Extended Release Drug Business (2017-2022)

Figure 56. Teva Revenue Growth Rate in Extended Release Drug Business (2017-2022)

Figure 57. Johnson & Johnson Revenue Growth Rate in Extended Release Drug Business (2017-2022)

Figure 58. Endo Pharmaceuticals Revenue Growth Rate in Extended Release Drug Business (2017-2022)

Figure 59. Purdue Pharma Revenue Growth Rate in Extended Release Drug Business (2017-2022)

Figure 60. Mylan Revenue Growth Rate in Extended Release Drug Business (2017-2022)

Figure 61. Hisamitsu Pharmaceutical Revenue Growth Rate in Extended Release Drug Business (2017-2022)

Figure 62. Sun Pharmaceutical Industries Revenue Growth Rate in Extended Release Drug Business (2017-2022)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Extended Release Drug Market Insights and Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-23G2678

Extended Release Drug Market Insights and Forecast to 2028

FEATURED COMPANIES

Extended Release Drug Market Outlook - 2028

Extended Release Drug Market Scope and Market Size

Segment by Type

Segment by Application

By Company

By Region

FEATURED COMPANIES